Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL COMPOUNDS
Document Type and Number:
WIPO Patent Application WO/2020/086650
Kind Code:
A3
Abstract:
The present disclosure relates to novel PDE2 inhibitory compounds of Formula I as described herein, their use as pharmaceuticals and pharmaceutical compositions comprising them.

More Like This:
JP6073923Condensation pyrrole as an IP receptor agonist for the medical treatment of pulmonary artery hypertension (PAH) and a related obstacle
WO/2013/015535NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS AN ACTIVE INGREDIENT
WO/1999/010350NITROGEN SUBSTITUTED IMIDAZO[4,5-c]PYRAZOLES AS CORTICOTROPIN RELEASING HORMONE ANTAGONISTS
Inventors:
LI PENG (US)
ZHENG HAILIN (US)
Application Number:
PCT/US2019/057549
Publication Date:
July 30, 2020
Filing Date:
October 23, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INTRA CELLULAR THERAPIES INC (US)
International Classes:
C07D487/04; A61P35/00; C07D519/00
Foreign References:
US20140066622A12014-03-06
Other References:
DATABASE Pubmed U.S. National Library of Medicine; 13 February 2015 (2015-02-13), "8-(3,3-Difluoroazetidin-1-yl)-3-methyl-1-[1- methyl-5-(4-methylphenyl)pyrazol-4-yl]imidazo[1,5-a]pyrazine", Database accession no. 89988495
DATABASE Pubmed U.S. National Library of Medicine; 13 February 2015 (2015-02-13), "8-(Azetidin-1-yl)-3-methyl-1-(1-methylpyrazol- 4-yl)imidazo[1,5-a]pyrazine", Database accession no. 89988494
Attorney, Agent or Firm:
TSIMARAS, Michael (US)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: IN VIVO OBJECT IDENTIFICATION, COUNTING, AND IMAGING BASED ON LIGHT BACKSCATTERED FROM A PLANE BEHIN...

Next Patent: CONVERTIBLE TRAY